0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover349.97%IV-72.22%PremiumJan 17, 2025Expiry Date6.50Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9756Delta0.0077Gamma1.36Leverage Ratio-0.0106Theta0.0012Rho1.33Eff Leverage0.0012Vega
Immersion Stock Discussion
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Monday, 16th December at 8:50 am
Successful Completion of All Planned Implants in GLP Study
enVVe Delivery System Demonstrates Consistent Performance
Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results
IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (NASDAQ: NVNO) ("enVVeno" or the "Company"), a compan...
Risk Level: 6 (Moderate Risk)
The risk assessment for Immersion Corporation at a score of 6 signifies moderate risk for potential investors. The company's fundamentals, such as solid profitability and reasonable P/E ratio, provide a cushion to investors; however, the absence of bullish news and lackluster sector interest increase the volatility risk. The stock's strong foundation with clear support levels counters some of the risk, but the limi...
oversold undervalued
P/L= +1.71%
loading...
loading...
No comment yet